Introduction
In 1958 Nelson reported a patient who developed an ACTHproducing tumour of the pituitary gland after bilateral adrenal-ectomy for Cushing's disease.' After the initial report Nelson described a further nine patients,2 and the syndrome now bears his name. These tumours are apt to be unusually aggressive, undergoing rapid expansion with compression and even invasion of suprasellar and parasellar structures.3 4 Surgical removal of the tumour, deep x-ray or heavy particle treatment, and a combination of these procedures have met with variable success. We describe here our experience with eight patients with Nelson's syndrome who were treated with a pituitary implant of I0Y or 198Au or a combination of both.
Patients and methods
Nelson's syndrome was defined as gross pigmentation with or without a radiologically evident pituitary tumour, developing after previous effective adrenalectomy and despite adequate replacement therapy. Three Plasma ACTH-Plasma ACTH was assayed by radioimmunoassay.7 The normal range at 9 am is < 10-80 ng/l.
Histology-The biopsy samples were processed as described.8 Immunostaining was carried out on formalin-fixed paraffin sections by the Coons's indirect technique. 9 Rabbit antiserum to human ACTH (Wellcome) was used as the first layer and fluorescein-conjugated goat anti-rabbit globulin (Hyland) as the second layer. Controls for immunostaining included the use of antihuman growth hormone, antihuman chorionic gonadotrophin (Wellcome), and non-immune rabbit serum as the first layer. The sera were diluted 1 in 10 with 0 01 m phosphate-buffered normal saline, pH 7-0.
Follow-up after pituitary implant-We usually re-admit patients for reassessment three months and one year after pituitary implantation and thereafter see them each year, unless they need more frequent follow-up. The mean period of follow-up in this series was five years (range three months to 13 years). One patient (case 6) died from an unrelated cause three years after his pituitary implant, and another (case 5) became an inpatient elsewhere because of another condition, so we had no follow-up information since the second year after her implant. At recent reassessments the patients had plasma ACTH assayed at 9.00 am and at midnight on two successive days, and on one of these days plasma ACTH was also assayed 60 and 120 minutes after their usual morning dose of corticosteroid. General pituitary function was tested by the combined pituitary function test,10 using gonadotrophin releasing hormone and thyrotrophin releasing hormone, and in some cases the insulin tolerance test.
Results
Pigmentation-In six patients skin pigmentation became normal; one patient (case 4) remained normally pigmented 13 years after implantation. There was almost complete loss of pigmentation in case 3 but only slight reduction in deep pigmentation in case 7.
Tumour growth-No patient developed new cranial nerve disease since implantation, and no patient showed further expansion of the pituitary fossa. After implantation a small reduction in the size of the sella was noted in case 5 after six months, and slight reossification of dorsum and lamina dura occurred in case 3 three years after. The other patients showed no significant change. In one patient (case 6) post-implant x-ray films were not available for comparison.
Plasma ACTH-The pre-and post-implant plasma ACTH levels are shown in table IV. Pre-implant plasma ACTH levels were grossly raised in all five patients assessed, and it is interesting to note that the levels fell sharply after the usual morning maintenance dose of steroid, although not into the normal range. At follow-up four patients (cases 1, 2, 4, and 5) had normal plasma levels and were all normally pigmented. In case 8 the levels fell substantially but were still abnormal; nevertheless, he was no longer pigmented. Case 7, who before implant had the highest plasma ACTH levels (and the largest tumour), still had very high plasma ACTH levels, although they were about 10o of the initial levels; he remained abnormally pigmented, although less so. Case 3 still had high plasma ACTH levels and was slightly pigmented. Histology-In all six patients who underwent biopsy light microscopy showed the presence of a basophil mucoid adenoma generally with moderately to well granulated cytoplasm in cells of small size containing small dense irregular ovoid nuclei. In case 3 nuclei were pleomorphic and vesicular. In case 7 the biopsy specimen in 1972 showed poor cytoplasmic staining while repeat biopsy at the time of reimplantation in 1974 showed moderate to marked granular cytoplasmic periodic-acid Schiff (PAS) positivity. Immunofluorescence (3 x 3600.) staining in cases 2, 7, and 8 was positive to only anti-ACTH, and the pattern of staining corresponded to the distribution of the PASpositive granules and to the electron-dense granules seen in the electron micrographs (fig 1) . Electron microscopy (in cases 2, 5, 7, and 8) showed variable numbers of cytoplasmic granules with typical appearances of ACTH (150-300 nm diameter), sometimes aligned along cell membranes. Endoplasmic reticulum was prominent in cases 2 and 7 but not in cases 5 and 8, which suggested that the latter patients had a lower level of secretory activity (fig 2) .
Discussion
The pituitary tumours that accompany Nelson's syndrome are apt to be unusually aggressive and their treatment is far from satisfactory. The number of treated cases reported is small, and it is often difficult to assess the efficacy of any treatment; many cases have been treated with a succession of procedures, which emphasises the resistance of these tumours to treatment. The response to external radiotherapy is on the whole poor, though a minority of patients have a good response.' 2 4 11-13 Surgical hypophysectomy has also had variable results. 2 The effect of the procedure seems to be long lasting: there were no subsequent relapses, and one patient (case 4) was still in clinical remission with normal plasma ACTH levels 13 years after the pituitary implant. There were few surgical or functional complications of the procedure. Pituitary implant thus compares favourably with the other procedures used for treating Nelson's syndrome.
This series was too small to show which type of radionuclide gave the best results. Each variety of pituitary implant used was followed with at least one good result. We no longer use a combination of 90Y and 198Au as it is technically difficult to insert accurately. Now we initially assess the size of the tumour with plain radiography, lateral hypocycloidal tomography, and air encephalography. In cases suitable for a pituitary implant 90Y calculated to give a dose of 150 000 rads to the gland periphery is used. If the dorsum sellae is severely eroded there would be inadequate landmarks for implantation; also extension of the subarachnoid space into the pituitary fossa would rule out a pituitary implant because of the danger of a CSF leak, and under these circumstances a transnasal hypophysectomy would be preferred. If the tumour has a large suprasellar extension ( > 8 mm on air encephalography) the patient would be referred for transfrontal craniotomy. In the event, only two patients were judged more suitable for open surgery.
Two out of four patients showed a clearly normal sella at adrenalectomy, thus showing that it is impossible to exclude the risk of Nelson's syndrome by radiological examination of the fossa. Indeed, one of these patients still had a normal sella at the time of diagnosis of Nelson's syndrome.
From the histopathological viewpoint the present series is the largest so far reported. Nelson et a12 noted that two of their patients had "chromophobe adenomas," a statement that can be interpreted in the light of our recent findings,8 as meaning active poorly granulated ACTH-secreting tumours. Riviere et a121 reported a case of Nelson's syndrome with light and electron microscopy findings similar to those described here, but no other biopsies seem to have been reported. Mucoid ACTH-secreting pituitary adenomas are probably central to this syndrome, but the relation of their origin to any presumptive hypothalamic disturbance is still obscure.
